Trial intelligence / Profile preview

Dobutamine for microcirculation in DIEP flap breast reconstruction

NL-OMON38526Recruiting

Sponsor
Orbis Medisch Centrum
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in breast cancer comparing Dobutamine intraoperative + postoperative placebo, Dobutamine intraoperative + postoperative dobutamine and Placebo intraoperative + postoperative placebo (3 arms). Primary endpoint: Increase in blood flow. Started Nov 2013; status: recruiting.

02

Drugs

dobutamine
03

Conditions

breast cancer

Beyond the preview

Go deeper on NL-OMON38526.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38526.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call